INTERVIEW: Merck Serono CEO On Growing In A Slowing China
This article was originally published in PharmAsia News
Executive Summary
Despite a slowing Chinese economy and a plethora of layoffs announced by multinational drug makers, Merck KGaA sees growth opportunities via localization and partnering in China. But MNCs have to fully grasp the volatility embedded in the emerging markets, says Merck Serono CEO Belén Garijo.